Variability of A beta removal after A beta 42 immunization in Alzheimer's disease

Variability of A beta removal after A beta 42 immunization in Alzheimer's disease

Bibliographic Details
Main Authors:	Boche, D, Bridges, L, Neal, J, Wilkinson, D, Holmes, C, Love, S, Esiri, M, Nicoll, J
Format:	Conference item
Published:	2007

Similar Items

Patients with Alzheimer’s disease have an increased removal rate of soluble beta-amyloid-42
by: Dmitry V. Zaretsky, et al.
Published: (2022-01-01)

Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
by: Diana K. Franco-Bocanegra, et al.
Published: (2019-11-01)

Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease
by: Emre Fertan, et al.
Published: (2023-02-01)

In silico study of traditional Chinese medicinal compounds targeting alzheimer's disease amyloid beta-peptide (1–42)
by: V. Naveen Kumar, et al.
Published: (2023-12-01)

Association Plasma Aβ42 Levels with Alzheimer’s Disease and Its Influencing Factors in Chinese Elderly Population
by: Wu Y, et al.
Published: (2022-08-01)

Tyramine and Amyloid Beta 42: A Toxic Synergy
by: Sudip Dhakal, et al.
Published: (2020-05-01)

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
by: Nicholas J Izzo, et al.
Published: (2014-01-01)

A beta 40 and A beta 42 Amyloid Fibrils Exhibit Distinct Molecular Recycling Properties
by: Sanchez, L, et al.
Published: (2011)

Beta-sheet structured oligomers of Alzheimer's beta-amyloid peptide perturb phosphatidylcholine model membranes
by: de Planque, M, et al.
Published: (2006)

An expeditious and facile method of amyloid beta (1-42) purification.
by: Md Aminul Haque, et al.
Published: (2024-01-01)

Changes in alpha- and beta-secretase in Alzheimer's disease
by: Tyler, S, et al.
Published: (2003)

Molecular simulation between amyloid beta (1-42), a Peptide associated with alzheimer disease, and zinc(ii) ion
by: Abdul Ghani, Nur Syafiqah
Published: (2016)

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease
by: Lambracht-Washington D, et al.
Published: (2013-08-01)

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2004)

Beta-amyloidolysis and glutathione in Alzheimer's disease
by: Lasierra-Cirujeda J, et al.
Published: (2013-04-01)

Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer’s Disease Patients
by: Felix Dinkel, et al.
Published: (2020-07-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1–42-induced Alzheimer's disease
by: Chao-Chao Yu, et al.
Published: (2018-01-01)

Comparison of the amyloid pore forming properties of rat and human Alzheimer’s beta-amyloid peptide 1-42: Calcium imaging data
by: Coralie Di Scala, et al.
Published: (2016-03-01)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
by: Julia Ring, et al.
Published: (2022-04-01)

alpha- and beta-secretase: profound changes in Alzheimer's disease.
by: Tyler, S, et al.
Published: (2002)

APOE epsilon 4 favours vascular over parenchymal deposition of A beta protein in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2002)

Serum amyloid beta 42 levels correlated with metabolic syndrome and its components
by: Kecheng Li, et al.
Published: (2024-02-01)

Coumarin derivatives against amyloid-beta 40 – 42 peptide and tau protein
by: Kowalczyk Joanna, et al.
Published: (2022-08-01)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
by: Nnana Amakiri, et al.
Published: (2019-05-01)

Quantitative and qualitative analysis of neuroinflammation by beta amyloid 1-42 toxin after treatment with resveratrol-loaded nanoparticles
by: Mariane Maria Silveira Vieira de Lima, et al.
Published: (2023-12-01)

Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity.
by: Iveta Vojtechova, et al.
Published: (2022-11-01)

Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus.
by: Allen, S, et al.
Published: (1991)

Ethnomedicinal Plants with Protective Effects against Beta-Amyloid Peptide (Aβ)1-42 Indicate Therapeutic Potential in a New In Vivo Model of Alzheimer’s Disease
by: Norah A. Althobaiti, et al.
Published: (2022-09-01)

Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (Aβ42) Peptide
by: Walter J. Lukiw, et al.
Published: (2019-12-01)

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
by: Blomqvist, M, et al.
Published: (2005)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
by: Anna M. de Kort, et al.
Published: (2023-06-01)

Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation
by: ALEJANDRO D ROTH, et al.
Published: (2005-01-01)

Experiences with beta radiation in ophthalmology
by: Holmes William
Published: (1953-01-01)

Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity
by: Liam G. Hall, et al.
Published: (2024-01-01)

Aggregation studies of the beta (34-42) peptide and synthesis of targets for amyloid staining and imaging
by: May, Christopher L. (Christopher Laurence)
Published: (2008)

Development of an Immunoassay for the Detection of Amyloid Beta 1-42 and Its Application in Urine Samples
by: Anurak Wongta, et al.
Published: (2020-01-01)

Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: O. Elaskalani, et al.
Published: (2018-05-01)

Hypochlorite-induced oxidation promotes aggregation and reduces toxicity of amyloid beta 1-42
by: Noralyn B. Mañucat-Tan, et al.
Published: (2023-07-01)